We are live on ! Find out more
DG

Delek Group Portfolio holdings

AUM $2.59B
1-Year Est. Return 1.24%
This Fund
S&P 500
This Quarter Est. Return
-16.41%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
-$191M
Cap. Flow
+$144M
Cap. Flow %
6.58%
Top 10 Hldgs %
23.34%
Holding
263
New
37
Increased
74
Reduced
71
Closed
47
Avg Time Held Equity + Options
2.9 quarters
Top 10 Avg Time Held Equity + Options
2.2 quarters
Top 20 Avg Time Held Equity + Options
2.6 quarters
Avg Time Held Equity only
3 quarters
Top 10 Avg Time Held Equity only
2.2 quarters
Top 20 Avg Time Held Equity only
2.6 quarters

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$36.2M
2
IFF icon
International Flavors & Fragrances
IFF
+$30.9M
3
DD icon
DuPont de Nemours
DD
+$25.5M
4
JPM icon
JPMorgan Chase
JPM
+$23.5M
5
OVV icon
Ovintiv
OVV
+$19.9M

Top Sells

Rank Stock Value
1
ORBK
Orbotech Ltd
ORBK
+$46.5M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$30.8M
3
AGN
Allergan plc
AGN
+$19.1M
4
VIRT icon
Virtu Financial
VIRT
+$17.3M
5
CPRI icon
Capri Holdings
CPRI
+$14M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.98%
2 Technology 16.06%
3 Healthcare 14.03%
4 Materials 8.78%
5 Energy 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VTRS icon
1
Viatris
VTRS
$20.1B
$85.8M 3.91%
3,047,957
+171,858
+6% +$5.57M
2017 Q4
4 quarters
ORA icon
2
Ormat Technologies
ORA
$5.64B
$67.6M 3.08%
1,256,474
+9,542
+0.8% +$502K
2017 Q4
4 quarters
TEVA icon
3
Teva Pharmaceutical Industries Limited
TEVA
$48B
$53.6M 2.45%
3,385,022
+1,767,313
+109% +$36.2M
2017 Q4
4 quarters
EEM icon
4
iShares MSCI Emerging Markets ETF
EEM
$30.7B
$52M 2.37%
1,294,646
-768,937
-37% -$30.8M
2017 Q4
4 quarters
MOS icon
5
The Mosaic Company
MOS
$5.99B
$49M 2.24%
1,632,018
+476,231
+41% +$15.7M
2017 Q4
4 quarters
TSEM icon
6
Tower Semiconductor
TSEM
$24.5B
$44.2M 2.01%
2,918,405
+651,123
+29% +$10.8M
2017 Q4
4 quarters
SEDG icon
7
SolarEdge
SEDG
$1.94B
$43.4M 1.98%
1,203,400
+196,332
+19% +$7.52M
2017 Q4
4 quarters
SPY icon
8
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$38.9M 1.77%
150,241
-307
-0.2% -$82.8K
2017 Q4
4 quarters
MLNX
9
DELISTED
Mellanox Technologies, Ltd.
MLNX
$38.7M 1.77%
408,439
-89,591
-18% -$7.61M
2017 Q4
4 quarters
IFF icon
10
International Flavors & Fragrances
IFF
$21.7B
$38.6M 1.76%
280,389
+223,589
+394% +$30.9M
2018 Q3
1 quarter
META icon
11
Meta Platforms (Facebook)
META
$1.89T
$38.4M 1.75%
284,536
+123,595
+77% +$17.9M
2017 Q4
4 quarters
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.27T
$32.6M 1.49%
613,620
– –
2017 Q4
4 quarters
BP icon
13
BP
BP
$120B
$30.9M 1.41%
817,912
+82,541
+11% +$3.3M
2017 Q4
4 quarters
DK icon
14
Delek US
DK
$4.74B
$29M 1.32%
868,035
+320,000
+58% +$12.1M
2017 Q4
4 quarters
MOS icon
15
PUT
The Mosaic Company
MOS
$5.99B
$26.2M 1.19%
895,500
+311,500
+53% +$10.3M
2018 Q1
3 quarters
CSTE icon
16
Caesarstone
CSTE
$95.4M
$26M 1.19%
1,864,517
– –
2017 Q4
4 quarters
OVV icon
17
Ovintiv
OVV
$18B
$25.7M 1.17%
864,650
+462,400
+115% +$19.9M
2018 Q3
1 quarter
ORCL icon
18
Oracle
ORCL
$416B
$25.2M 1.15%
543,075
-8,796
-2% -$422K
2017 Q4
4 quarters
CHKP icon
19
Check Point Software Technologies
CHKP
$13.7B
$24.9M 1.13%
235,588
– –
2017 Q4
4 quarters
TEVA icon
20
PUT
Teva Pharmaceutical Industries Limited
TEVA
$48B
$24.9M 1.13%
1,611,900
+412,300
+34% +$8.45M
2017 Q4
4 quarters
DD icon
21
DuPont de Nemours
DD
$17.5B
$24.7M 1.13%
+177,858
New +$25.5M
2018 Q4
0 quarters
MU icon
22
Micron Technology
MU
$1.12T
$24.6M 1.12%
740,216
+350,000
+90% +$13.3M
2017 Q4
4 quarters
ICL icon
23
ICL Group
ICL
$6.38B
$24M 1.1%
4,127,211
+112,332
+3% +$664K
2017 Q4
4 quarters
AAL icon
24
American Airlines Group
AAL
$8.35B
$22.2M 1.01%
673,459
+240,000
+55% +$8.35M
2018 Q3
1 quarter
JPM icon
25
JPMorgan Chase
JPM
$889B
$22.1M 1.01%
+220,347
New +$23.5M
2018 Q4
0 quarters
1
2 3 4 5

Similar funds

KPAG
KLS Professional Advisors Group New York $2.15B AUM 6.46% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
LC
Lourd Capital Beverly Hills, California $1.08B AUM 8.79% 1-Year Est. Return
LIC
Lodestar Investment Counsel Chicago, Illinois $974M AUM 13.79% 1-Year Est. Return
CB
Chemical Bank Detroit, Michigan $881M AUM 4.54% 1-Year Est. Return

Delek Group's Q4 2018 Portfolio in Review

As of Q4 2018, Delek Group held 263 positions worth $2.19B, down 8% from $2.38B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Delek Group deployed $144M of net new capital in Q4 2018, opening 37 new positions and adding to 74 existing holdings. Its largest new stake was DuPont de Nemours: 177,858 shares worth $24.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $30.8M trimmed.

  • Delek Group's largest Q4 2018 buy was DuPont de Nemours: 177,858 shares worth $24.7M.
  • Delek Group added most to Teva Pharmaceutical Industries Limited in Q4 2018, an estimated $36.2M increase.
  • Delek Group's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $30.8M.
  • Delek Group fully exited Orbotech Ltd in Q4 2018, selling an estimated $46.5M.
  • Delek Group's ten largest holdings make up 23% of its $2.19B portfolio in Q4 2018.
  • Delek Group opened 37 new positions and closed 47 in Q4 2018.
  • Delek Group's portfolio value fell 8% quarter-over-quarter to $2.19B.

Based on Delek Group's 13F filing for Q4 2018, filed 14 Feb 2019.